References
- The Pharmacological Basis of Therapeutics Weiner,N.;Gilman,A.G.(ed.);Goodman,L.S.(ed.);Gilman,A.(ed.)
- J. Cardiovascu. Pharmacol. v.9 Cardiovarcular effects of KM-13, a new, orally effective, cardiotonic sympathomimetics amine Caldwell,R.W.;Nash,C.B.;Smulkowski,M.;Tuttle,R.R.
- J. Pharmacol. Exp. & Ther. v.199 Disposition of dobutamine in dog Murphy,P.J.;Williams,T.L.;Kau,D.L.
- Yakhak Hoeji v.37 Synthesis of 4-(2'-(N-(1-methyl-3'-carbamylphenyl)-n-propyl))aminoethyl)-1-hydroxy-2-pyridone Yoon,S.H.
- J. Med. Chem. v.28 Dopamine receptor agonist of some 5-(2-aminoethyl)carbostyril Kaiser,C.;Dandridge,P.A.;Garney,E.;Flaim,K.E.;Zeid,R.L.;Hieble,J.P.
- J. Med. Chem. v.29 Syntheses and in vitro evaluation of 4-(2-amonoethyl)-2(3H)-indolone and related compounds as pheripheral prejunctional dopamine receptor agonists DeMarinus,R.M.;Gallagher,Jr.G.;Hall,R.F.;Franz,R.G.;Webster,C.;Huffman,R.F.;Schwartz,M.S.;Kaiser,C.;Ross,S.T.